secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alaunos Therapeutics, Inc. (TCRT)
CIK:        0001107421
Form:       8-K
Filed at:   2025-04-18T23:59:59+00:00
Accession:  0000950170-25-055903
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Robert Hofmeister resigns from Alaunos Therapeutics board effective April 15, 2025
--------------------------------------------------------------------------------

- Robert Hofmeister, Ph.D., resigned from the board with immediate effect on April 15, 2025.
- Resignation was not due to any disagreement on operations, policies, or practices.
- No replacement has been named by the company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1107421/000095017025055903/0000950170-25-055903-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1107421/000095017025055903/tcrt-20250415.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-055903

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer